According to a previous study based on microarray and RT-PCR, MSI2 expression increased slightly relative to normal tissue, but it is still used as a biomarker for gastric cancer (Emadi-Baygi et al., 2013; Yang et al., 2019). Here, MSI2 is linked to gastric cancer.